MAFFEZZOLI, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 736
NA - Nord America 710
EU - Europa 372
SA - Sud America 146
AF - Africa 44
OC - Oceania 2
Totale 2.010
Nazione #
US - Stati Uniti d'America 691
SG - Singapore 327
CN - Cina 159
IT - Italia 137
BR - Brasile 121
VN - Vietnam 88
HK - Hong Kong 76
DE - Germania 44
NL - Olanda 36
FR - Francia 31
GB - Regno Unito 29
ZA - Sudafrica 29
IN - India 25
IE - Irlanda 23
RU - Federazione Russa 18
AR - Argentina 14
KR - Corea 12
AT - Austria 11
SE - Svezia 11
BD - Bangladesh 9
CA - Canada 9
FI - Finlandia 8
JP - Giappone 7
MA - Marocco 7
IQ - Iraq 6
MX - Messico 6
PL - Polonia 6
ES - Italia 4
ID - Indonesia 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
EC - Ecuador 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
KE - Kenya 2
PE - Perù 2
TN - Tunisia 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 2.010
Città #
Singapore 204
Dallas 168
Ashburn 156
Hong Kong 75
Santa Clara 75
Beijing 45
Boardman 45
Ho Chi Minh City 38
Hefei 35
Johannesburg 28
Munich 25
Dublin 23
Milan 22
Los Angeles 21
Parma 18
Hanoi 15
Marseille 15
Modena 13
Shanghai 13
Buffalo 11
New York 11
Seoul 11
São Paulo 11
Brooklyn 9
Chennai 9
Bengaluru 8
Moscow 8
Paris 8
Denver 7
Nuremberg 7
Orem 7
Portsmouth 7
Rio de Janeiro 7
Tokyo 7
Atlanta 6
Columbus 6
Meknes 6
Poplar 6
Turku 6
Vienna 6
Amsterdam 5
Bologna 5
Council Bluffs 5
Stockholm 5
Da Nang 4
Houston 4
London 4
Montreal 4
Sungai Petani 4
Warsaw 4
Aachen 3
Bauru 3
Belo Horizonte 3
Brescia 3
Buenos Aires 3
Chicago 3
Düsseldorf 3
Frankfurt am Main 3
Genoa 3
Ninh Bình 3
Paderno Dugnano 3
Phoenix 3
Poços de Caldas 3
Quito 3
Salt Lake City 3
Scandiano 3
Tianjin 3
Ancona 2
Baghdad 2
Baku 2
Biên Hòa 2
Boston 2
Brussels 2
Busto Arsizio 2
Caxias do Sul 2
Curitiba 2
Dubai 2
Erbil 2
Felino 2
Foshan 2
Ha Long 2
Haiphong 2
Honolulu 2
Ivanovo 2
Jerago Con Orago 2
Lahore 2
Macaé 2
Manchester 2
Melbourne 2
Newark 2
Noida 2
North Bergen 2
Ottawa 2
Perugia 2
Ponta Grossa 2
Pune 2
Quezon City 2
Ribeirão Preto 2
Roubaix 2
San Francisco 2
Totale 1.359
Nome #
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review 154
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 119
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 108
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 98
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 96
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 95
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 92
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 91
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 89
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 88
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 84
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations 84
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. 80
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 73
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 71
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 65
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 63
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 60
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 57
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 57
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 56
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review 54
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental Survey 52
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 49
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 49
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? 39
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort 15
Totale 2.038
Categoria #
all - tutte 7.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025648 7 36 44 35 69 69 38 49 55 57 59 130
2025/20261.208 154 156 328 199 249 122 0 0 0 0 0 0
Totale 2.038